![](https://monteverdelaw.com/wp-content/uploads/case-logo/imara-inc.jpeg)
IMARA Inc. (IMRA), relating to its proposed merger with Enliven Therapeutics, Inc. Under the terms of the agreement, IMARA shareholders are expected to own approximately 16% of the combined company.
IMARA Inc. (IMRA), relating to its proposed merger with Enliven Therapeutics, Inc. Under the terms of the agreement, IMARA shareholders are expected to own approximately 16% of the combined company.